SenesTech, Inc.
SNESNasdaq
$1.42
↑ +0.7%Jul 17 close · end-of-day
Price
1Y↓ -70.6%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$7.5M
Enterprise Value
$670,478.14
P/E
—
P/S
3.4
P/B
1.0
EV/EBITDA
—
PEG
—
FCF Yield
-83.3%
Dividend Yield
—
Revenue (TTM)
$2.2M
Net Income (TTM)
-$6.8M
Free Cash Flow (TTM)
-$6.2M
Gross Margin
63.4%
Operating Margin
-312.3%
Net Margin
-304.2%
ROE
-88.0%
ROIC
-613.1%
Debt / Equity
—
Net Cash
$6.8M
Return 1Y
-69.6%
Company profile
SenesTech, Inc. develops technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and headquartered in Phoenix, Arizona.
- CEO
- Joel Fruendt
- Sector
- Manufacturing
- Industry
- Chemicals
- Employees
- 30
- Headquarters
- Arizona
- Website
- senestech.com
Earnings
SNES Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$493,000.00↑ +1.6%
Diluted EPS-$0.39↓ -69.5%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $282,000.00 | $600,000.00 | $1.0M | $1.2M | $1.9M | $2.2M |
| Gross profit | $1,000.00 | $244,000.00 | $464,000.00 | $539,000.00 | $1.0M | $1.4M |
| Operating income | -$7.9M | -$8.9M | -$9.7M | -$7.7M | -$6.2M | -$6.5M |
| Net income | -$8.4M | -$8.3M | -$9.7M | -$7.7M | -$6.2M | -$6.4M |
| Diluted EPS | — | -$14.77 | -$148.08 | -$115.10 | -$8.86 | -$1.95 |
| Operating cash flow | -$7.1M | -$7.8M | -$8.6M | -$7.6M | -$6.0M | -$5.8M |
| Free cash flow | -$7.2M | -$7.9M | -$8.8M | -$7.7M | -$6.1M | -$5.9M |
| Gross margin | 0.4% | 40.7% | 45.5% | 45.2% | 54.1% | 62.5% |
| Operating margin | -2813.1% | -1489.0% | -949.4% | -648.1% | -336.5% | -292.9% |
| Net margin | -2969.1% | -1378.0% | -951.4% | -646.3% | -333.0% | -287.4% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $459,000.00 | $482,000.00 | $501,000.00 | $485,000.00 | $625,000.00 | $690,000.00 | $421,000.00 | $493,000.00 |
| Gross profit | $249,000.00 | $315,000.00 | $305,000.00 | $313,000.00 | $409,000.00 | $433,000.00 | $233,000.00 | $338,000.00 |
| Operating income | -$1.6M | -$1.5M | -$1.3M | -$1.7M | -$1.6M | -$1.3M | -$1.9M | -$2.1M |
| Net income | -$1.6M | -$1.5M | -$1.3M | -$1.7M | -$1.6M | -$1.3M | -$1.8M | -$2.1M |
| Diluted EPS | -$3.08 | -$2.07 | -$0.15 | -$1.28 | -$0.87 | -$0.28 | $0.48 | -$0.39 |
| Operating cash flow | -$1.6M | -$1.4M | -$1.2M | -$1.6M | -$1.1M | -$1.4M | -$1.7M | -$1.9M |
| Free cash flow | -$1.6M | -$1.4M | -$1.2M | -$1.6M | -$1.2M | -$1.4M | -$1.7M | -$1.9M |
| Gross margin | 54.2% | 65.4% | 60.9% | 64.5% | 65.4% | 62.8% | 55.3% | 68.6% |
| Operating margin | -349.0% | -321.0% | -250.9% | -342.9% | -258.2% | -195.2% | -446.8% | -429.8% |
| Net margin | -345.1% | -313.9% | -250.5% | -343.3% | -258.6% | -188.1% | -428.5% | -418.5% |
Company news
Jun 29, 2026
Jun 4, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-07 | Edell Michael· Chief Executive Officer | Buy | 1,000 | $1.43 | $1,429.90 | filing |
| 2026-06-30 | GLENBROOK CAPITAL MANAGEMENT | Buy | 35,000 | $1.51 | $52,731.00 | filing |
| 2026-06-29 | GLENBROOK CAPITAL MANAGEMENT | Buy | 5,172 | $1.52 | $7,884.20 | filing |
| 2026-06-26 | GLENBROOK CAPITAL MANAGEMENT | Buy | 6,812 | $1.56 | $10,598.11 | filing |
| 2026-06-25 | GLENBROOK CAPITAL MANAGEMENT | Buy | 9,442 | $1.53 | $14,434.93 | filing |
| 2026-06-24 | GLENBROOK CAPITAL MANAGEMENT | Buy | 3,990 | $1.55 | $6,184.90 | filing |
| 2026-06-22 | GLENBROOK CAPITAL MANAGEMENT | Buy | 5,000 | $1.66 | $8,295.50 | filing |
| 2026-06-17 | GLENBROOK CAPITAL MANAGEMENT | Buy | 3,264 | $1.61 | $5,267.77 | filing |
| 2026-06-08 | GLENBROOK CAPITAL MANAGEMENT | Buy | 7,000 | $1.61 | $11,303.60 | filing |
| 2026-06-08 | Edell Michael· Chief Executive Officer | Buy | 1,000 | $1.55 | $1,550.00 | filing |
| 2026-06-05 | GLENBROOK CAPITAL MANAGEMENT | Buy | 13,159 | $1.57 | $20,684.63 | filing |
| 2026-06-04 | GLENBROOK CAPITAL MANAGEMENT | Buy | 8,230 | $1.65 | $13,547.40 | filing |
| 2026-05-18 | GLENBROOK CAPITAL MANAGEMENT | Buy | 10,000 | $1.59 | $15,878.00 | filing |
| 2026-05-15 | GLENBROOK CAPITAL MANAGEMENT | Buy | 7,120 | $1.65 | $11,746.58 | filing |
| 2026-05-15 | Edell Michael· Chief Executive Officer | Buy | 1,000 | $1.62 | $1,615.00 | filing |
| 2026-05-14 | GLENBROOK CAPITAL MANAGEMENT | Buy | 15,000 | $1.72 | $25,861.50 | filing |
| 2026-05-14 | Edell Michael· Chief Executive Officer | Buy | 2,000 | $1.70 | $3,397.60 | filing |
| 2026-04-28 | GLENBROOK CAPITAL MANAGEMENT | Buy | 3,000 | $1.47 | $4,407.00 | filing |
| 2026-03-17 | GLENBROOK CAPITAL MANAGEMENT | Buy | 19,725 | $1.79 | $35,355.09 | filing |
| 2026-03-16 | GLENBROOK CAPITAL MANAGEMENT | Buy | 5,060 | $1.86 | $9,392.37 | filing |
| 2026-03-13 | GLENBROOK CAPITAL MANAGEMENT | Buy | 146,249 | $1.95 | $285,434.17 | filing |
| 2026-02-19 | GLENBROOK CAPITAL MANAGEMENT | Buy | 34,613 | $2.40 | $83,140.43 | filing |
| 2026-02-18 | GLENBROOK CAPITAL MANAGEMENT | Buy | 10,481 | $2.29 | $24,001.49 | filing |
| 2026-02-17 | GLENBROOK CAPITAL MANAGEMENT | Buy | 40,807 | $2.29 | $93,492.92 | filing |
| 2026-02-13 | GLENBROOK CAPITAL MANAGEMENT | Buy | 15,390 | $1.89 | $29,105.57 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.